Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  


ASTER DM HEALTHCARE 2020-21 Annual Report Analysis
Wed, 31 Mar

ASTER DM HEALTHCARE has announced its results for the year ended March 2021. Let us have a look at the detailed performance review of the company during FY20-21.

ASTER DM HEALTHCARE Income Statement Analysis

  • Operating income during the year fell 0.5% on a year-on-year (YoY) basis.
  • The company's operating profit decreased by 13.1% YoY during the fiscal. Operating profit margins witnessed a fall and stood at 12.8% in FY21 as against 14.7% in FY20.
  • Depreciation charges increased by 5.4% and finance costs decreased by 14.6% YoY, respectively.
  • Other income grew by 32.0% YoY.
  • Net profit for the year declined by 44.6% YoY.
  • Net profit margins during the year declined from 3.6% in FY20 to 2.0% in FY21.

ASTER DM HEALTHCARE Income Statement 2020-21

No. of Mths Year Ending 12 Mar-20* 12 Mar-21* % Change
Net Sales Rs m 86,519 86,084 -0.5%
Other income Rs m 379 500 32.0%
Total Revenues Rs m 86,898 86,584 -0.4%
Gross profit Rs m 12,691 11,027 -13.1%
Depreciation Rs m 5,859 6,176 5.4%
Interest Rs m 3,908 3,336 -14.6%
Profit before tax Rs m 3,302 2,015 -39.0%
Tax Rs m 154 272 77.0%
Profit after tax Rs m 3,149 1,743 -44.6%
Gross profit margin % 14.7 12.8
Effective tax rate % 4.7 13.5
Net profit margin % 3.6 2.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



New Research: 2 stocks to buy as Nifty50 heads towards 40,000

ASTER DM HEALTHCARE Balance Sheet Analysis

  • The company's current liabilities during FY21 down at Rs 32 billion as compared to Rs 37 billion in FY20, thereby witnessing an decrease of -14.1%.
  • Long-term debt down at Rs 18 billion as compared to Rs 19 billion during FY20, a fall of 7.3%.
  • Current assets fell 11% and stood at Rs 36 billion, while fixed assets fell 4% and stood at Rs 80 billion in FY21.
  • Overall, the total assets and liabilities for FY21 stood at Rs 116 billion as against Rs 124 billion during FY20, thereby witnessing a fall of 6%.

ASTER DM HEALTHCARE Balance Sheet as on March 2021

No. of Mths Year Ending 12 Mar-20* 12 Mar-21* % Change
Networth Rs m 32,721 33,725 3.1
 
Current Liabilities Rs m 37,221 31,956 -14.1
Long-term Debt Rs m 18,922 17,548 -7.3
Total Liabilities Rs m 124,053 116,200 -6.3
 
Current assets Rs m 40,957 36,290 -11.4
Fixed Assets Rs m 83,097 79,910 -3.8
Total Assets Rs m 124,053 116,200 -6.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



ASTER DM HEALTHCARE Cash Flow Statement Analysis

  • ASTER DM HEALTHCARE's cash flow from operating activities (CFO) during FY21 stood at Rs 16 billion, an improvement of 28.3% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY21 stood at Rs -3 billion on a YoY basis.
  • Cash flow from financial activities (CFF) during FY21 stood at Rs -11 billion on a YoY basis.
  • Overall, net cash flows for the company during FY21 stood at Rs 1 billion from the Rs -1 billion net cash flows seen during FY20.

ASTER DM HEALTHCARE Cash Flow Statement 2020-21

Particulars No. of months 12 12 % Change
Year Ending Mar-20 Mar-21
Cash Flow from Operating Activities Rs m 12,233 15,691 28.3%
Cash Flow from Investing Activities Rs m -6,673 -3,303 -
Cash Flow from Financing Activities Rs m -6,748 -11,161 -
Net Cash Flow Rs m -1,099 1,199 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for ASTER DM HEALTHCARE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 3.5, an decline from the EPS of Rs 6.3 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 137.3, stands at 39.3 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 2.0 times, while the price to sales ratio stands at 0.8 times.
  • The company's price to cash flow (P/CF) ratio stood at 8.3 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-20* 12 Mar-21*
Sales per share (Unadj.) Rs 174.2 173.2
TTM Earnings per share Rs 6.3 3.5
Diluted earnings per share Rs 6.3 3.5
Price to Cash Flow x 5.3 8.3
TTM P/E ratio x 15.1 39.3
Price / Book Value ratio x 2.0 1.9
Market Cap Rs m 64,336 65,348
Dividends per share (Unadj.) Rs 0.0 0.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for ASTER DM HEALTHCARE

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 1.1x during FY21, from 1.1x during FY20. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 1.6x during FY21, from 1.8x during FY20. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 5.2% during FY21, from 9.6% during FY21. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 10.4% during FY21, from 14.0% during FY20. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 4.4% during FY21, from 5.7% during FY20. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-20* 12 Mar-21*
Current ratio x 1.1 1.1
Debtors’ Days Days 10 9
Interest coverage x 1.8 1.6
Debt to equity ratio x 0.6 0.5
Return on assets % 5.7 4.4
Return on equity % 9.6 5.2
Return on capital employed % 14.0 10.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how ASTER DM HEALTHCARE has performed over the last 5 years, please visit here.

ASTER DM HEALTHCARE Share Price Performance

Over the last one year, ASTER DM HEALTHCARE share price has moved up from Rs 95.5 to Rs 137.3, registering a gain of Rs 41.9 or around 43.8%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 21,328.2 (up 0.4%). Over the last one year it has moved up from 12,148.6 to 21,328.2, a gain of 9,180 points (up 75.6%).

Overall, the S&P BSE SENSEX is up 74.1% over the year.

(To know more, check out historical annual results for ASTER DM HEALTHCARE and quarterly results for ASTER DM HEALTHCARE)

Annual Report FAQs

What is the current share price of ASTER DM HEALTHCARE?

ASTER DM HEALTHCARE currently trades at Rs 409.2 per share. You can check out the latest share price performance of ASTER DM HEALTHCARE here...

What was the revenue of ASTER DM HEALTHCARE in FY21? How does it compare to earlier years?

The revenues of ASTER DM HEALTHCARE stood at Rs 86,584 m in FY21, which was down -0.4% compared to Rs 86,898 m reported in FY20.

ASTER DM HEALTHCARE's revenue has grown from Rs 59,679 m in FY17 to Rs 86,584 m in FY21.

Over the past 5 years, the revenue of ASTER DM HEALTHCARE has grown at a CAGR of 9.7%.

What was the net profit of ASTER DM HEALTHCARE in FY21? How does it compare to earlier years?

The net profit of ASTER DM HEALTHCARE stood at Rs 1,743 m in FY21, which was down -44.6% compared to Rs 3,149 m reported in FY20.

This compares to a net profit of Rs 3,676 m in FY19 and a net profit of Rs 2,794 m in FY18.

Over the past 5 years, ASTER DM HEALTHCARE net profit has grown at a CAGR of 15.6%.

What does the cash flow statement of ASTER DM HEALTHCARE reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of ASTER DM HEALTHCARE reveals:

  • Cash flow from operations increased in FY21 and stood at Rs 15,691 m as compared to Rs 12,233 m in FY20.
  • Cash flow from investments increased in FY21 and stood at Rs -3,303 m as compared to Rs -6,673 m in FY20.
  • Cash flow from financial activity decreased in FY21 and stood at Rs -11,161 m as compared to Rs -6,748 m in FY20.

Here's the cash flow statement of ASTER DM HEALTHCARE for the past 5 years.

(Rs m)FY17FY18FY19FY20FY21
From Operations3,6085,3746,00912,23315,691
From Investments-11,527-5,225-7,089-6,673-3,303
From Financial Activity6,5384571,344-6,748-11,161
Net Cashflow-1,217606329-1,0991,199

What does the Key Ratio analysis of ASTER DM HEALTHCARE reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of ASTER DM HEALTHCARE reveals:

  • Operating profit margins witnessed a fall and stood at 12.8% in FY21 as against 14.7% in FY20.
  • Net profit margins declined from 3.6% in FY20 to 2.0% in FY21.
  • Debt to Equity ratio for FY21 stood at 0.5 as compared to 0.6 in FY20.

Here's the ratio/financial analysis of ASTER DM HEALTHCARE for the past 5 years.

 FY17FY18FY19FY20FY21
Operating Profit Margin (%)12.911.311.114.712.8
Net Profit Margin (%)1.64.24.63.62.0
Debt to Equity Ratio (x)1.00.60.60.60.5

Read: Latest Annual Report Analysis of ASTER DM HEALTHCARE

Equitymaster requests your view! Post a comment on "ASTER DM HEALTHCARE 2020-21 Annual Report Analysis". Click here!